The U.S. Food and Drug Administration (FDA) released a new draft guidance on Container Closure Systems for Human Drugs and Biological Products in August 2026.

The draft provides guiding principles for evaluating the quality of container closure systems used to package human drugs and biological products. Although it is currently a draft and does not establish legally enforceable requirements, it is an important development for pharmaceutical manufacturers and packaging suppliers to follow.

What Is a Container Closure System?

A container closure system includes the packaging components that together provide protection for a drug product.

For pharmaceutical manufacturers, packaging is not simply an external container. The packaging system needs to protect the product while maintaining its quality, safety, identity, strength, and purity throughout its intended use.

This makes packaging selection an important part of pharmaceutical product development.

Why Is Pharmaceutical Packaging Important?

Pharmaceutical products may be sensitive to moisture, oxygen, contamination, light, and interaction with packaging materials.

The packaging therefore needs to provide appropriate protection while remaining compatible with the formulation.

For topical products such as ointments, creams, and gels, the relationship between the pharmaceutical formulation and the packaging material is particularly important.

Packaging manufacturers and pharmaceutical companies may need to consider factors such as:

* Material compatibility
* Internal coating performance
* Container integrity
* Chemical stability
* Microbial limits
* Manufacturing environment
* Quality control
* Packaging specifications

What Does This Mean for Pharmaceutical Aluminum Tubes?

Aluminum tubes are commonly used for ointments, creams, gels, lotions, and other topical healthcare products.

However, selecting a pharmaceutical aluminum tube should involve more than choosing the correct diameter and capacity.

The pharmaceutical manufacturer should also evaluate the tube material, internal coating, tube integrity, manufacturing environment, quality control system, and compatibility with the formulation.

A suitable packaging solution needs to be considered together with the pharmaceutical product itself.

Why Internal Coating Matters

For pharmaceutical aluminum tubes, the internal coating can be an important part of the packaging system.

The coating helps separate the pharmaceutical formulation from the aluminum substrate and can play an important role in maintaining compatibility between the packaging and the product.

Therefore, pharmaceutical companies should discuss formulation compatibility and relevant testing requirements with their packaging supplier during product development.
What Should Pharmaceutical Companies Ask Their Tube Supplier?

When evaluating a pharmaceutical aluminum tube supplier, buyers may want to ask:

1. What materials are used for the tube?
2. What internal coating options are available?
3. How is the manufacturing environment controlled?
4. What quality tests are performed?
5. Can the supplier provide relevant technical documentation?
6. Does the supplier have experience with pharmaceutical applications?
7. Can the tube dimensions and specifications be customized?
8. Can the supplier support compatibility or stability-related evaluation?

These questions can help pharmaceutical companies evaluate packaging suppliers more systematically.

Controlled Manufacturing Environment

Pharmaceutical packaging requires appropriate manufacturing controls.

Xinrontube manufactures pharmaceutical aluminum tubes in controlled cleanroom environments. The company's existing product information describes eight ISO 8 cleanrooms based on the ISO 14644-1 classification system and continuous monitoring of environmental parameters during production.

For pharmaceutical packaging buyers, a controlled manufacturing environment can be an important factor when evaluating supplier capabilities.

What Does the FDA Draft Mean for Packaging Suppliers?

The new FDA draft guidance is another reminder that pharmaceutical packaging should be considered as part of the overall quality of a drug product.

For packaging suppliers, this means that product specifications, manufacturing controls, material selection, testing, documentation, and communication with pharmaceutical customers all remain important.

A supplier that understands these considerations can provide more value than simply manufacturing a packaging component.

What Should Companies Do Now?

The FDA document is currently a draft guidance and should not be treated as a final regulatory requirement.

Pharmaceutical companies should review the official FDA document and evaluate whether its principles are relevant to their own products and packaging development processes.

The FDA has stated that comments on the draft should be submitted by October 13, 2026.

For pharmaceutical packaging projects, early communication between the pharmaceutical manufacturer and packaging supplier can also help identify potential compatibility, quality, and regulatory considerations before commercial production.

Pharmaceutical Aluminum Tube Packaging from Xinrontube

Xinrontube specializes in pharmaceutical-grade collapsible aluminum tubes for ointments, creams, gels, lotions, and other topical healthcare applications.

The company provides different tube diameters and capacities and manufactures pharmaceutical packaging in controlled cleanroom production environments.

For pharmaceutical companies evaluating aluminum tube packaging, Xinrontube can discuss tube specifications, application requirements, manufacturing conditions, and customized packaging solutions.

Contact Xinrontube to discuss your pharmaceutical aluminum tube packaging requirements.